Healthcare spending for the privately insured increased 3.4% in 2014 despite a decline in the use of healthcare services.
Healthcare spending for the privately insured increased 3.4% in 2014 despite a decline in the use of healthcare services, according to a report from the Health Care Cost Institute (HCCI).
The 2014 Health Care Cost and Utilization Report analyzes healthcare spending trends for Americans young than the age of 65 years and covered by employer-sponsored insurance from 2010 to 2014. Over the 5-year period per capita spending growth grew between 3% and 4% each year.
The report found that spending on brand prescription drugs increased by $45 per capita in 2014 despite a 16% decrease in the use of these drugs. The report attributes the increase in spending to the use of the hepatitis C drugs Olysio, Sovaldi, and Havoni.
“It’s striking to see the impact high priced drugs can have on health care spending, particularly in the case of three hepatitis C drugs, where use is relatively low,” HCCI Senior Researcher Amanda Frost, said in a statement. “With more high-priced drugs set to enter the market, higher spending on brand prescriptions is a potential trend to watch.”
In 2014, the largest decline in healthcare service utilization was for acute admissions (-2.7%) and the largest average price increase was for acute inpatient admissions, which increased $831 per admission (4.6%).
HCCI found that women spend more out of pocket each year, with the difference between what men and women spend reaching $237 in 2014, and the gap between the young and the old increased. In 2010, the difference between the oldest and youngest age groups was $6281, which increased to $6806 in 2014.
“We’re pleased to release our fifth annual health care spending report,” said HCCI Executive Director David Newman. “With the implementation of the Affordable Care Act, HCCI looks forward over the coming years to continue its analysis of health care trends, tracking any changes brought by the ACA in order to aid and improve the U.S. health care system.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More